Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

被引：41

作者：

So, Brian J. ^{[1
]}

Bekaii-Saab, Tanios ^{[1
]}

Bloomston, Mark A. ^{[1
]}

Patel, Tushar ^{[1
]}

机构：

[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2008年 / 1卷 / 1期

关键词：

Renal Cell Carcinoma; Complete Remission; Sorafenib; Gastrointestinal Stromal Tumor; Hemochromatosis;

D O I：

10.1186/1756-8722-1-18

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies have shown that sorafenib, a multikinase inhibitor, can reduce tumor progression in patients with this cancer. However, complete remission has not been observed. We report a case of a 78-year old patient with unresectable metastatic hepatocellular carcinoma who had a rapid and complete clinical response following therapy with sorafenib for six months. No evidence of disease recurrence has been noted for 6 months after discontinuation of therapy.

引用

页数：3

共 50 条

[21] Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
Shu-Guang Zhu
Hai-Bo Li
Ze-Nan Yuan
Wei Liu
Qing Yang
Ying Cheng
Wen-Jing Wang
Guo-Ying Wang
Hua Li
World Journal of Gastrointestinal Oncology, 2020, (10) : 1209 - 1215
[22] Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report
Liu, Zhaonan
Li, Xingjie
He, Xuequn
Xu, Yingchun
Wang, Xi
BMC CANCER, 2019, 19 (01)
[23] Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report
Zhaonan Liu
Xingjie Li
Xuequn He
Yingchun Xu
Xi Wang
BMC Cancer, 19
[24] Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
Zhu, Shu-Guang
Li, Hai-Bo
Yuan, Ze-Nan
Liu, Wei
Yang, Qing
Cheng, Ying
Wang, Wen-Jing
Wang, Guo-Ying
Li, Hua
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (10) : 1209 - 1215
[25] Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report
Cui, Kai
Li, Zhongchao
Zhong, Jingtao
Shi, Xuetao
Zhao, Lei
Li, Hao
Ma, Ying
FRONTIERS IN ONCOLOGY, 2024, 14
[26] Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report
Isoda, Bunpei
Shiga, Masanobu
Kandori, Shuya
Nagumo, Yoshiyuki
Yoshino, Takayuki
Ikeda, Atsushi
Kawahara, Takashi
Kimura, Tomokazu
Negoro, Hiromitsu
Hoshi, Akio
Mathis, Bryan J.
Nishiyama, Hiroyuki
CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 429 - 433
[27] Complete response to nivolumab for metastatic renal cell carcinoma on hemodialysis patient; a case report
Ito, Akito
Hisano, Mizuki
Takahashi, Makoto
Komine, Naoki
Abe, Takaya
Obara, Wataru
UROLOGY CASE REPORTS, 2020, 28
[28] Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver.: A case report
Köhler, HH
Höhler, T
Küsel, U
Kirkpatrick, CJ
Schirmacher, P
PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (07) : 509 - 513
[29] Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
Shiozawa, Kazue
Watanabe, Manabu
Ikehara, Takashi
Matsukiyo, Yasushi
Kogame, Michio
Kanayama, Masahiro
Matsui, Teppei
Kikuchi, Yoshinori
Ishii, Koji
Igarashi, Yoshinori
Sumino, Yasukiyo
ONCOLOGY LETTERS, 2014, 7 (01) : 50 - 52
[30] Complete Regression of Recurrent Advanced Hepatocellular Carcinoma After Liver Transplantation in Response to Sorafenib Treatment: A Case Report
Lee, H. Y.
Yang, K. H.
Choi, B. H.
Park, Y. M.
Yoon, K. T.
Ryu, J. H.
Chu, C. W.
TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 247 - 250

← 1 2 3 4 5 →